Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

被引：0
|
作者：
Massimo Volpe
Alejandro de la Sierra
Bettina Ammentorp
Petra Laeis
机构：
[1] University of Rome “La Sapienza”,Division of Cardiology, Department of Clinical and Molecular Medicine
[2] Sant’Andrea Hospital,Department of Internal Medicine, Hospital Mutua Terrassa
[3] IRCCS Neuromed,undefined
[4] University of Barcelona,undefined
[5] Daiichi Sankyo Europe GmbH,undefined
来源：
Advances in Therapy | 2014年 / 31卷
关键词：
Cardiology; Hypertension; Olmesartan/amlodipine/hydrochlorothiazide; Open-label; Seated diastolic blood pressure; Seated systolic blood pressure; Triple combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：561 / 574
页数：13
相关论文
共 50 条
  • [21] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
    Neutel, Joel M.
    Giles, Thomas D.
    Punzi, Henry
    Weiss, Robert J.
    Li, Huiling
    Finck, Amy
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
  • [22] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [23] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
  • [24] Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study (vol 6, pg 132, 2012)
    Chrysant, Steven G.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2013, 7 (04) : 325 - 325
  • [25] EFFICACY AND SAFETY OF ALISKIREN/AMLODIPINE OR ALISKIREN/AMLODIPINE/HYDROCHLOROTHIAZIDE COMBINATIONS: A 18-WEEK, OPEN-LABEL STUDY IN PATIENTS WITH STAGE II HYPERTENSION IN THAILAND
    Vichairuangthum, Kitigon
    Chotnaparatpat, Paiboon
    JOURNAL OF HYPERTENSION, 2015, 33 : E5 - E5
  • [26] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
    David A. Calhoun
    Nora A. Crikelair
    Joseph Yen
    Robert D. Glazer
    Advances in Therapy, 2009, 26 : 1012 - 1023
  • [27] COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION .2. AN OPEN LONG-TERM STUDY OF EFFICACY AND SAFETY
    HEIDBREDER, D
    FROER, KL
    BAUER, B
    CAIRNS, V
    BREITSTADT, A
    BENDER, N
    CLINICAL CARDIOLOGY, 1993, 16 (01) : 47 - 52
  • [28] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
    Calhoun, David A.
    Crikelair, Nora A.
    Yen, Joseph
    Glazer, Robert D.
    ADVANCES IN THERAPY, 2009, 26 (11) : 1012 - 1023
  • [29] Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study
    Philipp, Thomas
    Glazer, Robert D.
    Zhao, Yanxing
    Pospiech, Rainer
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 187 - 193
  • [30] Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial
    Oparil, S.
    Chrysant, S. G.
    Melino, M.
    Lee, J.
    Karki, S.
    Heyrman, R.
    JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (12) : 831 - 838
12345